Communicating with CVM

Similar documents
Suitability Petition (SP)

SUMMARY: The Food and Drug Administration (FDA) is proposing to amend its regulations

Formal Dispute Resolution: Appeals Above the Division Level Guidance for Industry and Review Staff

Guidance for the public, FDA Advisory Committee Members, and FDA Staff: The Open Public Hearing at FDA Advisory Committee Meetings

Food and Drug Administration Modernization Act of 1997: Modifications to the List of

The Declaration of Added Sugars on Honey, Maple Syrup, and Certain Cranberry Products;

Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification Products;

Request for Notification from Industry Organizations Interested in Participating in the

Laser Products--Conformance with IEC Ed. 3 and IEC Ed. 3.1 (Laser

FDA REFORM LEGISLATION Its Effect on Animal Drugs TABLE OF CONTENTS

Center for Devices and Radiological Health Appeals Processes: Questions and Answers About 517A

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing the

United States. Country QUESTIONNAIRE

Indirect Food Additives: Adhesives and Components of Coatings. SUMMARY: The Food and Drug Administration (FDA or we) is amending the food additive

Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Overthe-Counter

Determination of Regulatory Review Period for Purposes of Patent Extension; XIENCE

FREEDOM OF INFORMATION ACT AND THE FDA

Coronary, Peripheral, and Neurovascular Guidewires--Performance Tests and

Subpart A General Provisions PART 7 ENFORCEMENT POLICY. 21 CFR Ch. I ( Edition)

Citation to Code of Federal Regulations and statutory citation (as applicable):

Sunscreen Feedback Letters; Notice of Availability Under the Sunscreen Innovation Act

Review of Existing General Regulatory and Information Collection Requirements of the

=======================================================================

Subpart A General Provisions

Refurbishing, Reconditioning, Rebuilding, Remarketing, Remanufacturing, and Servicing of

Internal Agency Review of Decisions; Requests for Supervisory Review of Certain. Decisions Made by the Center for Devices and Radiological Health

PHARMACEUTICAL LAW GROUP PC

Guidance for Industry

Criteria Used to Order Administrative Detention of Food for Human or Animal

PART 7 ENFORCEMENT POLICY

Case 1:14-cv TSC Document Filed 01/22/16 Page 1 of 5 EXHIBIT 65

Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs,

The Consumer Healthcare Products Association (CHPA) submits these. comments on the proposal published by the Food and Drug Administration (FDA) in 64

NOV PROPOSAL TO DEBAR NOTICE OF OPPORTUNITY FOR HEARING Docket No. OON-1530

Proposal to Refuse to Approve a New Drug Application for Oxycodone Hydrochloride

COLORADO DEPARTMENT OF REGULATORY AGENCIES. Division of Professions and Occupations. Office of Naturopathic Doctors COLORADO REGULATIONS (CCR) 749-1

Case 1:16-cv Document 1 Filed 06/06/16 Page 1 of 9

FDA-2010-N-0371 FDA-2010-D-0354

SUMMARY: The Food and Drug Administration (FDA or we) is reinstating the provision

CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH)

WASHINGTON LEGAL FOUNDATION

APPENDIX: COMPARATIVE MATRIX

NUCLEAR REGULATORY COMMISSION. [Docket Nos and EA ; NRC ] In the Matter of Energy Northwest; Columbia Generating Station

Subpart K Administrative Detention of Food for Human or Animal Consumption. Food and Drug Administration, HHS 1.379

October 15, 2018 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Before the Federal Communications Commission Washington, D.C ) ) ) ) ) ) ) ) ) )

SUBCHAPTER B PROCEDURAL RULES

Agreement between the Federal Trade Commission (FTC) and the Consumer Financial Protection Bureau (CFPB) regarding FOIA consultations, 2012

Amendments to Regulations on Citizen Petitions, Petitions for Stay of Action, and Submission of

SUMMARY: This proposed rule would address recommendations submitted to the

DEPARTMENT OF TRANSPORTATION. Hours of Service of Drivers: Application for Exemption; SikhsPAC and the North American Punjabiz Trucker Association

2018 Dairy Policy: the Good, the Bad and the Ugly. Mary Knigge Dairy Farmers of America Vice President, Government Relations

NUCLEAR REGULATORY COMMISSION. [Docket Nos and ; NRC ] Exelon Generation Company, LLC

AGENCY: United States Patent and Trademark Office, Commerce. SUMMARY: The United States Patent and Trademark Office (USPTO) has modified

Official Solicitor: Appointment in Family Proceedings

o 1205 Culbreth Dr., Suite 200, Wilmington, NC Phone : Facsimile :

Exelon Generation Company, LLC; Peach Bottom Atomic Power Station, Units 2. ACTION: Intent to conduct scoping process and prepare environmental impact

SUMMARY: The Food and Drug Administration (FDA) is issuing a final rule that adopts,

Pharmacy Law Update. Brian E. Dickerson. Partner FisherBroyles, LLP Attorneys at Law

HOGAN & HARTSON APR -9 P4 :18 BY HAND DELIVERY

WASHINGTON LEGAL FOUNDATION

ROUTINE ACCESS POLICY. For the Nova Scotia Workers Compensation Appeals Tribunal. October 2003 (Revised April 2005)

ADOPTED REGULATION OF THE NEVADA STATE BOARD OF VETERINARY MEDICAL EXAMINERS. LCB File No. R057-00

Freedom of Information. How it works inside the box

The only witness details shown on the front of the MG11 form relate to their name and age:

Concurrent Session III March 6, Investigating Allegations of Scientific Misconduct and the False Claims Act

POCKET REFERENCE DRUG SAMPLE DISTRIBUTION: SELECT FEDERAL LAWS AND REGULATIONS

Freedom of Information Act 2000 (FOIA) Environmental Information Regulations 2004 (EIR) Decision notice

Freedom of Information Act 2000 (FOIA) Decision notice

NUCLEAR REGULATORY COMMISSION [NRC ] Qualification of Safety-Related Lead Storage Batteries for Nuclear Power Plants

Office of Surface Mining Reclamation and Enforcement. AGENCY: Office of Surface Mining Reclamation and Enforcement, Interior.

ACTION: License amendment application; notice of opportunity to comment, request a

FDA WARNING LETTERS. FDA s Warning Letter Process and How to Respond

federal register Department of Health and Human Services Part III Wednesday December 3, 1997 Food and Drug Administration

POLICY AND PROCEDURES OFFICE OF THE CENTER DIRECTOR. Drug Safety Oversight Board (DSB) Table of Contents

[NRC ] Mr. Joseph Quintanilla is a radiographer who was formerly employed by Quality

How to file a complaint against Netcare Medical Scheme

Small Business Regulatory Enforcement Fairness Act of 1996 (P.L )

Codex Alimentarius Commission: Meeting of the Codex. AGENCY: Office of the Deputy Under Secretary for Food

Policies and Procedures Massachusetts Veterinary Medical Association

Freedom of Information Act 2000 (FOIA) Decision notice

Agency Information Collection Activities; Revision of a Currently Approved Collection:

Case 1:07-cv RMU Document 71-2 Filed 05/08/2007 Page 1 of 6. ANDA , Amlodipine Besylate Tablets, 2.5 mg, 5 mg, and 10 mg.

MEMORANDUM. Joseph A. Levitt Elizabeth Barr Fawell. Date: December 21, Congress Passes Landmark Food Safety Legislation

Guidance for handling requests to access information from social work records received from the Police

R.P ADM-9-03 OT:RR:RD:TC H RES DEPARTMENT OF HOMELAND SECURITY BUREAU OF CUSTOMS AND BORDER PROTECTION 19 CFR PART 101

3 3/3&l MAR~ DEi ARTMENT OF IX&XlX & HUMAN SERVICES Public Health Service. via Federal Express

9 CFR Parts 301,304,316,317,318,319,320,327,362,381,412 and 416. Revision of the Nutrition Facts Labels for Meat and Poultry

ACCREDITED STANDARDS COMMITTEE (ASC) Z540 OPERATING PROCEDURES 2016

U.S. Department of Homeland Security Citizenship and Immigration Services Administrative Appeals Office

Federal Register / Vol. 75, No. 193 / Wednesday, October 6, 2010 / Rules and Regulations

HEALTH AND SAFETY CODE TITLE 2. HEALTH SUBTITLE G. LICENSES CHAPTER 141. YOUTH CAMPS

FREEDOM OF INFORMATION ACT POLICY

Freedom of Information Act 2000 (FOIA) Decision notice

proposes to add a new system of records in its inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C.

Approved: Effective: May 18, 2018 Review: December 27, 2016 Office: Director of Administration Topic No.: l MEMBERSHIP DUES

TABLE OF CONTENTS. Part I: Background and Regulatory Framework. Part II: MDUFMA, 510(k) and Validation

Freedom of Information Act 2000 (FOIA) Decision notice

UNRAVELING THE MYSTERY OF THE CHARACTER AND FITNESS PROCESS

FDA APPEALS IMPROVING YOUR ODDS OF SUCCESS: TRENDS, EXPECTATIONS, STRATEGIES. Jeffrey Shapiro

Transcription:

Communicating with CVM Diane L. Heinz, DVM, MBA Director, Policy and Regulations Staff Center for Veterinary Medicine, FDA CVM s s Website Information related to recalls, including pet food How to file pet food complaints How to report an adverse event Following CVM on Twitter Sign up to receive CVM Updates, notices, etc., via: Email Updates RSS Feed Links to a variety of CVM topics and offices CVM s s Website http://www.fda.gov/animalveterinary/default.htm 1

Communication Staff Mailing address: Communications Staff (CVM) Food and Drug Administration 7519 Standish Place HFV-12 Rockville, MD 20855 Phone: 240-276 276-9300 Email: AskCVM@fda.hhs.gov Federal Register FDA announces most activity in the Federal Register, including but not limited to: Rules Guidances Meeting notices Requests for public comments Others ADDRESSES section of each FR notice specifies where you can send comments For Further Information Contact section provides contact information for the FDA employee who can assist with questions Federal Register http://www.fda.gov/regulatoryinformation/dockets/fr/default.htm.htm 2

Federal Register http://www.fda.gov/animalveterinary/default.htm Regulations Guidances Guidance documents represent the Agency's current thinking on a regulatory issue do not have the force and effect of law advisory You can comment on a guidance at both the draft and final stages or any time after publication of the final guidance 3

Guidances http://www.fda.gov/animalveterinary/default.htm Guidances http://www.fda.gov/animalveterinary/guidancecomplianceenforcement/guidanceforindustry/default.htm Guidances Under Development 4

Public Meetings FDA periodically holds meetings and workshops to which the public is invited Recent example - Veterinary Medical Advisory Committee Meeting related to Genetically Engineered Salmon, held September 19-20, 2010 FDA publishes notices of public meetings in the Federal Register in advance of each meeting Notices include date, time, location, and other relevant information Notices also include contact information for FDA staff who can assist if you have questions Public Meetings http://www.fda.gov/animalveterinary/newsevents/workshopsconferencesmeetings/default.htm Citizen Petitions Citizen Petition process is used to request the Commissioner to issue, amend, or revoke a regulation or order, or to take or refrain from taking any other form of administrative action Submit written petitions to the Division of Dockets Management (HFA-305) as instructed in 21 CFR Sec. 10.30. If petition complies with Sec. 10.30, DDM will assign docket number and forward to the appropriate Center within FDA Policy and Regulations, my office, handles CVM s response to citizen petitions 5

Dockets Management Contact Information Dockets Management - the official repository for the administrative proceedings and rule-making documents Dockets Management is administered by the Federal Dockets Management System (FDMS) Your can search the Dockets Management database at http://www.regulations.gov Submit comments related to FDA actions to the docket specified in the Federal Register notice that announces that action Dockets Management Contact Information Submit written submissions (including Docket Number) to: Division of Dockets Management Food and Drug Administration 5630 Fishers Lane Room 1061, HFA-305 Rockville, MD 20852 Phone: 301-827 827-6860 Fax: 301-827 827-6870 Congressional Inquiries Members of Congress communicate through FDA s Office of Legislation Members of Congress have different and more requests than members of the public, including: requests for information on specific CVM programs or policies requests for information on behalf of constituents requesting witnesses to appear at hearings requesting technical assistance when drafting legislation 6

Freedom of Information Requests FOIA requests must be in writing and should include the following information: Requestor's name, address, and telephone number Description of the records being sought Separate requests for each firm or product involved A statement concerning willingness to pay fees, including any limitations. Freedom of Information Requests All FOIA requests must be in writing Requests should be mailed to the following address: Food and Drug Administration Division of Freedom of Information (HFI-35) Office of Shared Services Office of Public Information and Library Services 5600 Fishers Lane Rockville, MD 20857 You may fax your request to: 301-443 443-1726 or 301-443 443-1719 Address questions about FOI requests to the Division of the Freedom of Information Offices at 301-827 827-6567 FOIA Electronic Reading Room http://www.fda.gov/aboutfda/centersoffices/cvm/cvmfoiaelectronicreadingroom/default.htm 7

CVM Ombudsman assists in resolving disputes with affected persons and groups both inside and outside the Center investigates complaints involving science, science- based policy decisions, and administrative procedures reports complaint findings and helps achieve equitable solutions serves as CVM s s contact for information on the dispute resolution process CVM s s Ombudsman http://www.fda.gov/aboutfda/centersoffices/cvm/cvmombudsman/default.htm When to Contact The Ombudsman: For complaints or disputes involving CVM science-based programs, policies and procedures, and guidance documents and for comments or suggestions on how they can be improved. When an applicant does not know where or how to begin an appeal, little progress is being made going up the chain of command, or about a matter that has not been resolved in the supervisory chain of command procedure. At any time before or during the dispute resolution process Remember: CVM s s Ombudsman does not handle matters that are already involved in litigation. 8

FDA Veterinarian http://www.fda.gov/animalveterinary/newsevents/fdaveterinariannewsletter/default.htm CVM s s Website http://www.fda.gov/animalveterinary/default.htm Questions? 9